111 related articles for article (PubMed ID: 26345631)
61. The Evolutionary Conserved SWI/SNF Subunits ARID1A and ARID1B Are Key Modulators of Pluripotency and Cell-Fate Determination.
Pagliaroli L; Trizzino M
Front Cell Dev Biol; 2021; 9():643361. PubMed ID: 33748136
[TBL] [Abstract][Full Text] [Related]
62. mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.
Cremosnik GS; Mesrouze Y; Zueger P; Furkert D; Grandjean F; Argoti D; Mermet-Meillon F; Bauer MR; Brittain S; Rogemoser P; Yang W; Giovannoni J; McGregor L; Tang J; Knapp M; Holzinger S; Buhr S; Muller L; Leder L; Xie L; Fernandez C; Nieto-Oberhuber C; Chène P; Galli GG; Sesterhenn F
ACS Chem Biol; 2024 May; 19(5):1142-1150. PubMed ID: 38655884
[TBL] [Abstract][Full Text] [Related]
63. Involvement of transcribed lncRNA uc.291 and SWI/SNF complex in cutaneous squamous cell carcinoma.
Mancini M; Cappello A; Pecorari R; Lena AM; Montanaro M; Fania L; Ricci F; Di Lella G; Piro MC; Abeni D; Dellambra E; Mauriello A; Melino G; Candi E
Discov Oncol; 2021 May; 12(1):14. PubMed ID: 35201472
[TBL] [Abstract][Full Text] [Related]
64. [Multiple primary malignancies combined with SWI/SNF complex-deficient gastric cancer: a case report and literature review].
Lü C; Wu X; Xia Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):495-498. PubMed ID: 37087597
[TBL] [Abstract][Full Text] [Related]
65. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.
Barisic D; Chin CR; Meydan C; Teater M; Tsialta I; Mlynarczyk C; Chadburn A; Wang X; Sarkozy M; Xia M; Carson SE; Raggiri S; Debek S; Pelzer B; Durmaz C; Deng Q; Lakra P; Rivas M; Steidl C; Scott DW; Weng AP; Mason CE; Green MR; Melnick A
Cancer Cell; 2024 Apr; 42(4):720-722. PubMed ID: 38593783
[No Abstract] [Full Text] [Related]
66. Loss of SWI/SNF complex expression in undifferentiated renal carcinoma in acquired cystic kidney.
Kojima F; Ueda Y; Matsuzaki I; Hara I; Murata SI
Pathol Int; 2018 Apr; ():. PubMed ID: 29671925
[No Abstract] [Full Text] [Related]
67. Epigenetic inhibitors for the precision treatment of
Fukumoto T; Zhang R; Bitler BG
Expert Rev Precis Med Drug Dev; 2018; 3(4):233-236. PubMed ID: 30525111
[No Abstract] [Full Text] [Related]
68. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
[TBL] [Abstract][Full Text] [Related]
69. Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis.
Luchini C; Veronese N; Solmi M; Cho H; Kim JH; Chou A; Gill AJ; Faraj SF; Chaux A; Netto GJ; Nakayama K; Kyo S; Lee SY; Kim DW; Yousef GM; Scorilas A; Nelson GS; Köbel M; Kalloger SE; Schaeffer DF; Yan HB; Liu F; Yokoyama Y; Zhang X; Pang D; Lichner Z; Sergi G; Manzato E; Capelli P; Wood LD; Scarpa A; Correll CU
Oncotarget; 2015 Nov; 6(36):39088-97. PubMed ID: 26384299
[TBL] [Abstract][Full Text] [Related]
70. SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.
Kim KH; Kim W; Howard TP; Vazquez F; Tsherniak A; Wu JN; Wang W; Haswell JR; Walensky LD; Hahn WC; Orkin SH; Roberts CW
Nat Med; 2015 Dec; 21(12):1491-6. PubMed ID: 26552009
[TBL] [Abstract][Full Text] [Related]
71. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.
Gossai N; Biegel JA; Messiaen L; Berry SA; Moertel CL
Am J Med Genet A; 2015 Dec; 167A(12):3186-91. PubMed ID: 26364901
[TBL] [Abstract][Full Text] [Related]
72. Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
PeerJ; 2024; 12():e16923. PubMed ID: 38374950
[TBL] [Abstract][Full Text] [Related]
73. Thoracic SMARCA4-deficient undifferentiated tumor.
Jiang J; Chen Z; Gong J; Han N; Lu H
Discov Oncol; 2023 Apr; 14(1):51. PubMed ID: 37115343
[TBL] [Abstract][Full Text] [Related]
74. Primary proximal epithelioid sarcoma of the lung: A case report and review of the literature.
Li J; Zhou Y; Liu Y
Histol Histopathol; 2024 Jan; 39(1):49-56. PubMed ID: 36999367
[TBL] [Abstract][Full Text] [Related]
75. SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics.
Al-Shbool G; Krishnan Nair H
Cureus; 2022 Oct; 14(10):e30708. PubMed ID: 36439610
[TBL] [Abstract][Full Text] [Related]
76. Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas.
Urer HN; Unver N; Fener N
Turk Patoloji Derg; 2023; 39(2):147-153. PubMed ID: 36178285
[TBL] [Abstract][Full Text] [Related]
77. SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution.
Sun S; Li Q; Zhang Z; Xiong S; Zhang Y; Liu Q; Li Z; Yang F; Zhang S
Environ Health Prev Med; 2022; 27():3. PubMed ID: 35289322
[TBL] [Abstract][Full Text] [Related]
78. SMARCA4-deficient rectal carcinoma with a sarcomatoid component: a case report.
Meda Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Kiriyama A; Fujino M
Clin J Gastroenterol; 2022 Apr; 15(2):419-426. PubMed ID: 35129794
[TBL] [Abstract][Full Text] [Related]
79. Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer.
Musolf AM; Simpson CL; Moiz BA; Pikielny CW; Middlebrooks CD; Mandal D; de Andrade M; Cole MD; Gaba C; Yang P; You M; Li Y; Kupert EY; Anderson MW; Schwartz AG; Pinney SM; Amos CI; Bailey-Wilson JE
Cancer Res; 2021 Jun; 81(12):3162-3173. PubMed ID: 33853833
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
